Notice: Constant DATE_RFC7231 already defined in /var/www/weitzman/public_html/includes/bootstrap.inc on line 258
Diabetes e-Co-System™ | Weitzman Institute

Diabetes e-Co-System™

Completed: 
1
Study Name: 
Phase II: Building a “Diabetes e-Co-System™”
Study Period: 
August 1, 2011 to August 1, 2013
Funder: 
Sanofi-Aventis
Principal Investigators: 
Victor Villagra, MD (Health & Technology Vector); Ed Fisher, PhD (University of North Carolina at Chapel Hill)
Description: 

Poorly controlled diabetes and co-morbidities represent a significant service and fiscal burden to the health care system. Data from 2003-2004 NHANES showed that approximately 40% of patients on oral agents alone were not on HbA1c target. The primary care nurse provider is central to CHC’s planned care, patient-centered model, assuming responsibility for primary prevention (vaccines and immunizations, health education), delegated nurse visits (Coumadin management, hypertension follow up), health education, triage and quality control. This is a two year trial for high risk patients with diabetes, using direct nursing support, group visits, panel management, and peer support.

Significance: 

This project hopes to deliver more, better and more coordinated care to a cohort of poorly controlled diabetics. The demonstration will position the Diabetes e-Co-System™ to satisfy key requisites for a successful Medical Home functioning as part of a future Accountable Care Organization. In addition, selected short-term clinical indicators associated with the preservation of end-organ function and reduction of cardiovascular risk will be improved, including HbA1c, LDL cholesterol, blood pressure, and renal function tests.